Haloperidol (haloperidol lactate) NDC 55154-9553

NDC codes

FDA NDC Directory

Product NDC (as listed)55154-9553Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55154-9553Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55154-9553-5	55154955305	5 VIAL in 1 BAG (55154-9553-5) / 1 mL in 1 VIALMarketed from Dec 15, 2010

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Haloperidol
Generic name (nonproprietary): haloperidol lactate
Active ingredients: Haloperidol lactate — 5 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular
Labeler: Cardinal Health 107, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075689
Marketing start: Dec 15, 2010
Listing expires: Dec 31, 2027
Identifiers: Product ID 55154-9553_8f42fe3c-28ff-419f-8fae-4be430c1643dSPL ID 8f42fe3c-28ff-419f-8fae-4be430c1643dSPL set ID e2eed126-cb82-42b1-9b48-9cbeb6873b50RxCUI 1719646UNII 6387S86PK3UPC 0055154955355
Pharmacologic class: Typical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N455154955305 followed by a unit qualifier and the quantity

Package 55154-9553-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 18, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Haloperidol injection is indicated for the treatment of patients with schizophrenia.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 075689

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075689
Product	Strength	Form · route	Labeler	Product NDC
Haloperidolhaloperidol lactate	Haloperidol lactate 5 mg/mL	Injection, SolutionIntramuscular	HF Acquisition Co LLC, DBA HealthFirst	51662-1524
Haloperidolhaloperidol lactate	Haloperidol lactate 5 mg/mL	Injection, SolutionIntramuscular	Fresenius Kabi USA, LLC	63323-474
Haloperidolhaloperidol lactate	Haloperidol lactate 5 mg/mL	Injection, SolutionIntramuscular	REMEDYREPACK INC.	70518-0035